The effects of NK4 on viral myocarditis mice

Cardiovascular Pathology

Volumn 18, Issue 6, 2009, Pages 323-331

  Shen, Difei ^a   Tang, Qizhu ^a   Huang, Zhengrong ^b   Chen, Ying ^c   Xiong, Ran ^a   Wu, Hui ^a   Huang, Ji ^a   Feng, Siting ^a   Yan, Ling ^a   Bian, Zhouyan ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b Xiamen First Hospital   (China)

^c Hubei Maternal and Child Health Hospital   (China)

Author keywords

Hepatocyte growth factor; Myocarditis; NK4

Indexed keywords

ANGIOTENSIN II; ANTIVIRUS AGENT; COLLAGEN; GELATINASE B; NK 4; SCATTER FACTOR; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIOVASCULAR EFFECT; CELL COUNT; CONTROLLED STUDY; CONVALESCENCE; COXSACKIE VIRUS B3; COXSACKIE VIRUS INFECTION; DENSITY; DRUG MECHANISM; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; MALE; MICROVASCULATURE; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; VIRUS MYOCARDITIS;

ANGIOGENESIS INHIBITORS; ANIMALS; APOPTOSIS; COXSACKIEVIRUS INFECTIONS; CYTOKINES; ECHOCARDIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATOCYTE GROWTH FACTOR; IN SITU NICK-END LABELING; MALE; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED BALB C; MYOCARDITIS; MYOCARDIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 70350567767     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2008.10.008     Document Type: Article

References (36)

1. Zarnegar R., and Michalopoulos G.K. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol 129 (1995) 1177-1180
2. Matsumoto K., and Nakamura T. Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun 239 (1997) 639-644
3. Birchmeier C., and Gherardi E. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol 8 (1998) 404-410
4. Jeffers M., Rong S., and Vande Woude G.F. Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis. J Mol Med 74 (1996) 505-513
5. To C.T., and Tsao M.S. The roles of hepatocyte growth factor/scatter factor and Met receptor in human cancers. Oncol Rep 5 (1998) 1013-1024
6. Jiang W.G., Hiscox S., Matsumoto K., et al. Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer. Crit Rev Oncol Hematol 29 (1999) 209-248
7. Rosen E.M., Lamszus K., Laterra J., et al. HGF/SF in angiogenesis. Ciba Found Symp 212 (1997) 215-229
8. Nakamura T., Mizuno S., Matsumoto K., et al. Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J Clin Invest 106 (2000) 1511-1519
9. Taniyama Y., Morishita R., Nakagami H., et al. Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters. Circulation 102 (2000) 246-252
10. Saraste A., Arola A., Vuorinen T., et al. Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis. Cardiovasc Pathol 12 (2003) 255-262
11. Colston J.T., Chandrasekar B., and Freeman G.L. Expression of apoptosis-related proteins in experimental coxsackievirus myocarditis. Cardiovasc Res 38 (1998) 158-168
12. Fairweather D., Frisancho-Kiss S., Yusung S.A., et al. Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart. Am J Pathol 165 (2004) 1883-1894
13. Suddaby E.C. Viral myocarditis in children. Crit Care Nurse 16 (1996) 73-82
14. Futamatsu H., Suzuki J., Mizuno S., et al. Hepatocyte growth factor ameliorates the progression of experimental autoimmune myocarditis: a potential role for induction of T helper 2 cytokines. Circ Res 96 8 (2005) 823-830
15. Isobe M., Futamatsu H., and Suzuki J. Hepatocyte growth factor: effects on immune-mediated heart diseases. Trends Cardiovasc Med 16 6 (2006) 188-193
16. Matsumoto K., and Nakamura T. NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics. Cancer Sci 9 (2003) 4321-4327
17. Maemondo M., Narumi K., Saijo Y., et al. Targeting angiogenesis and HGF function using an adenoviral vector expressing the HGF-antagonist NK4 for cancer therapy. Mol Ther 5 (2002) 177-185
18. Hirao S., Yamada Y., Koyama F., et al. Tumor suppression effect using NK4, a molecule acting as an antagonist of HGF, on human gastric carcinomas. Cancer Gene Ther 9 (2002) 700-707
19. Saimura M., Nagai E., Mizumoto K., et al. Intraperitoneal injection of adenovirus-mediated NK4 gene suppresses peritoneal dissemination of pancreatic cancer cell line AsPC-1 in nude mice. Cancer Gene Ther 9 (2002) 799-806
20. He C.S., Wilhelm S.M., Pentland A.P., et al. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci U S A 86 (1989) 2632-2636
21. Li Y.Y., McTiernan C.F., and Feldman A.M. Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells. Cardiovasc Res 42 (1999) 162-172
22. Li Y.Y., McTiernan C.F., and Feldman A.M. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovasc Res 46 (2000) 214-224
23. Thomas C.V., Coker M.L., Zellner J.L., et al. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circulation 97 (1998) 1708-1715
24. Brauer P.R., and Cai D.H. Expression of tissue inhibitor of metalloproteinases (TIMPs) during early cardiac development. Mech Dev 113 (2002) 175-179
25. Spinale F.G., Coker M.L., Krombach S.R., et al. Matrix metalloproteinase inhibition during the development of congestive heart failure: effects on left ventricular dimensions and function. Circ Res 85 (1999) 364-376
26. Fujiuchi Y., Nagakawa O., Murakami K., et al. Effect of hepatocyte growth factor on invasion of prostate cancer cell lines. Oncol Rep 10 (2003) 1001-1006
27. Mizuno S., Kurosawa T., Matsumoto K., et al. Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J Clin Invest 101 (1998) 1827-1834
28. Hanatani A., Yoshiyama M., Kim S., et al. Inhibition by angiotensin II type 1 receptor antagonist of cardiac phenotypic modulation after myocardial infarction. J Mol Cell Cardiol 27 (1995) 1905-1914
29. Shiota N., Fukamizu A., Takai S., et al. Activation of angiotensin II-forming chymase in the cardiomyopathic hamster heart. J Hypertens 15 (1997) 431-440
30. Danser A.H., van-Kesteren C.A., Bax W.A., et al. Prorenin, renin, angiotensinogen, and angiotensin-converting enzyme in normal and failing human hearts: evidence for renin binding. Circulation 96 (1997) 220-226
31. Urata H., Boehm K.D., Philip A., et al. Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J Clin Invest 91 (1993) 1269-1281
32. Nakamura F., Nagano M., Kobayashi R., et al. Chronic administration of angiotensin II receptor antagonist, TCV-116, in cardiomyopathic hamsters. Am J Physiol Heart Circ Physiol 267 (1994) H2297-H2304
33. Watanabe M., Kawaguchi H., Onozuka H., et al. Chronic effects of enalapril and amlodipine on cardiac remodeling in cardiomyopathic hamster hearts. J Cardiovasc Pharmacol 32 (1998) 248-259
34. Daisaku T., Naoki M., Keiji K., et al. Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model. Cancer Res 61 (2001) 7518-7524
35. Kuba K., Matsumoto K., Date K., et al. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. Cancer Res 606 (2000) 737-6743
36. Kuba K., Matsumoto K., Ohnishi K., et al. Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells. Biochem Biophys Res Commun 279 (2000) 846-852